CASI Pharma (CASI) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
As of March 31, 2016, CASI had cash and cash equivalents of $13.9 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- First Acceptance (FACO) Tops Q3 EPS by 16c
- Weis Markets (WMK) Tops Q3 EPS by 90c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
